GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

Ранг среди акций #3775
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Цена акции
$25.73
Рыночная капитализация
$4.36B
Изменение (1 день)
-5.33%
Изменение (1 год)
-17.92%
Страна
IN
Торговля GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Категория

Healthcare
История цены акций GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Наивысшая цена закрытия: $28.33 2026-10-01

Наименьшая цена закрытия: $7.46 1999-01-01
История цены акций GlaxoSmithKline Pharmaceuticals Limited с 1999 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -0.80%
2025 3.53%
2024 30.13%
2023 28.84%
2022 -31.26%
2021 11.05%
2020 -8.11%
2019 15.01%
2018 5.68%
2017 -5.61%
2016 -18.58%
2015 0.11%
2014 11.37%
2013 16.93%
2012 5.11%
2011 -25.99%
2010 39.42%
2009 47.96%
2008 -8.92%
2007 -0.02%
2006 7.37%
2005 41.03%
2004 38.71%
2003 85.99%
2002 3.08%
2001 -33.62%
2000 -42.61%
1999 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$1.31K 60.86%
US
$268.67 39.25%
US
$284.42 24.38%
US
$148.33 69.31%
US
$482.01 30.76%
CH